The condition is called chronic thromboembolic pulmonary hypertension — or CTEPH — a rare complication of the acute clotting ...

The Chronic Thromboembolic Pulmonary Hypertension drugs in development market research report provides comprehensive information on the therapeutics under development for Chronic Thromboembolic ...

The trial will have two parts, with part one assessing the safety, tolerability and pharmacological profile of single ascending oral doses of CS014. Part two will explore the treatment candidate’s ...

According to Madani, surgical director of the CTEPH program at UC San Diego Health, the clots in Washburn’s lungs were both ...

prospectively collected data on consecutive CTEPH patients from 34 PH centers worldwide in 20 countries. Patients were required to be enrolled within 12 months of diagnosis and to be naïve to ...

Of patients who completed the survey, 91% were pleased with home treatment, and 92% were satisfied with the support and instruction they received regarding outpatient treatment. Seventy percent of ...

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving ...

Over a median 3.7 years, 11 of the 30 people with PAH worsened and required either additional treatment or a lung transplant, or died. Each loss of one capillary per mm doubled the risk of clinical ...

The stigma linking HIV to the LGBTQ+ community led to poor funding for treatment and unfair treatment for those diagnosed with the virus in areas such as housing, work, and other parts of society.

The European Chronic Thromboembolic Pulmonary Hypertension registry (CTEPH), conducted between 2007 and 2012, reported the major impact of pulmonary endarterectomy (PEA) on the long-term survival of ...